Maurizio Fava, MD, will take on the expanded role of chair of psychiatry for Mass General Brigham (MGB) as Scott Rauch, MD, transitions out of his roles of chair of psychiatry and psychiatrist-in-chief for McLean Hospital on November 1.
In this role, Dr. Fava will lead psychiatry across MGB’s academic medical centers (AMCs) and McLean Hospital, bringing together psychiatry faculty as one department, with a single leader and with a unified vision for excellence in clinical care, research, education and community health. Since becoming AMC chair of psychiatry in October 2024, Dr. Fava has demonstrated outstanding leadership, fostering collaboration with faculty at McLean and strengthening integration across the system. The psychiatry programs at Massachusetts General Hospital and McLean Hospital were recently named the #1 and #2 hospitals for psychiatry care in the nation by U.S. News & World Report in their annual “Best Hospitals” honor roll for 2025-2026.
Dr. Fava is internationally recognized for his groundbreaking work in depression and research to improve psychiatric care. He founded the Depression Clinical and Research Program at Mass General and the Mass General Psychiatry Clinical Trials Network and Institute, co-led STARD — the largest depression trial ever conducted —and he has published more than 1,000 articles and chapters. His leadership and scientific rigor continue to shape the field and elevate our collective mission. Dr. Fava will work closely with Dr. Rauch between now and November 1 to lay the foundation for the integration of the McLean Department of Psychiatry into MGB’s academic medical center Department of Psychiatry.
“Ours is already the nation’s leading psychiatry program, and Dr. Fava’s commitment to research and clinical innovation, partnership and patient-centered care has already made a meaningful impact,” says David F. M. Brown, MD, president of academic medical centers for Mass General Brigham. “We are grateful to Dr. Scott Rauch for his leadership and confident in Dr. Fava’s ability to guide our psychiatry programs into a bold future.”
